Figure 9 provides a comprehensive visual summary of the experimental model, the key markers of colitis assessed, and the observed effects of the treatments on DAI scores, MPO activity, cytokine suppression, GLP-1 restoration, and safety-related endpoints. The gene discussed is MPO; the disease is colitis.